» Articles » PMID: 18286689

Infant Intestinal Enterococcus Faecalis Down-regulates Inflammatory Responses in Human Intestinal Cell Lines

Overview
Specialty Gastroenterology
Date 2008 Feb 21
PMID 18286689
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To investigate the ability of Lactic acid bacteria (LAB) to modulate inflammatory reaction in human intestinal cell lines (Caco-2, HT-29 and HCT116). Different strains of LAB isolated from new born infants and fermented milk, together with the strains obtained from culture collections were tested.

Methods: LABs were treated with human intestinal cell lines. ELISA was used to detect IL-8 and TGF-beta protein secretion. Cytokines and Toll like receptors (TLRs) gene expression were assessed using RT-PCR. Conditional medium, sonicated bacteria and UV killed bacteria were used to find the effecter molecules on the bacteria. Carbohydrate oxidation and protein digestion were applied to figure out the molecules' residues. Adhesion assays were further carried out.

Results: It was found that Enterococcus faecalis is the main immune modulator among the LABs by downregulation of IL-8 secretion and upregulation of TGF-beta. Strikingly, the effect was only observed in four strains of E. faecalis out of the 27 isolated and tested. This implies strain dependent immunomodulation in the host. In addition, E. faecalis may regulate inflammatory responses through TLR3, TLR4, TLR9 and TRAF6. Carbohydrates on the bacterial cell surface are involved in both its adhesion to intestinal cells and regulation of inflammatory responses in the host.

Conclusion: These data provide a case for the modulation of intestinal mucosal immunity in which specific strains of E. faecalis have uniquely evolved to maintain colonic homeostasis and regulate inflammatory responses.

Citing Articles

: an overlooked cell invader.

Archambaud C, Nunez N, da Silva R, Kline K, Serror P Microbiol Mol Biol Rev. 2024; 88(3):e0006924.

PMID: 39239986 PMC: 11426025. DOI: 10.1128/mmbr.00069-24.


Mini-review: microbiota have potential to prevent PEDV infection by improved intestinal barrier.

Yang S, Liu G, Savelkoul H, Jansen C, Li B Front Immunol. 2023; 14:1230937.

PMID: 37503350 PMC: 10369048. DOI: 10.3389/fimmu.2023.1230937.


Therapeutic and prophylactic effects of oral administration of probiotic Enterococcus faecium Smr18 in Salmonella enterica-infected mice.

Rashid M, Narang A, Thakur S, Jain S, Kaur S Gut Pathog. 2023; 15(1):23.

PMID: 37208771 PMC: 10197331. DOI: 10.1186/s13099-023-00548-x.


Anti-inflammatory and wound healing properties of lactic acid bacteria and its peptides.

Saravanan P, R P, Balachander N, K K, S S, S R Folia Microbiol (Praha). 2023; 68(3):337-353.

PMID: 36780113 PMC: 9924211. DOI: 10.1007/s12223-022-01030-y.


Recombinant Muscovy Duck Parvovirus Led to Ileac Damage in Muscovy Ducklings.

He J, Zhang Y, Hu Z, Zhang L, Shao G, Xie Z Viruses. 2022; 14(7).

PMID: 35891451 PMC: 9315717. DOI: 10.3390/v14071471.


References
1.
Sullivan P, Gaillard J, Franklin M, Jones R . The effects of ultraviolet radiation on antibiotic-resistant bacteria in vitro. Ostomy Wound Manage. 1998; 44(10):50-6. View

2.
Isolauri E, Kirjavainen P, Salminen S . Probiotics: a role in the treatment of intestinal infection and inflammation?. Gut. 2002; 50 Suppl 3:III54-9. PMC: 1867676. DOI: 10.1136/gut.50.suppl_3.iii54. View

3.
Salaun B, Coste I, Rissoan M, Lebecque S, Renno T . TLR3 can directly trigger apoptosis in human cancer cells. J Immunol. 2006; 176(8):4894-901. DOI: 10.4049/jimmunol.176.8.4894. View

4.
Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M . Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol. 2000; 164(7):3476-9. DOI: 10.4049/jimmunol.164.7.3476. View

5.
Cross M, Gill H . Can immunoregulatory lactic acid bacteria be used as dietary supplements to limit allergies?. Int Arch Allergy Immunol. 2001; 125(2):112-9. DOI: 10.1159/000053804. View